1991
DOI: 10.1016/0002-9149(91)90817-5
|View full text |Cite
|
Sign up to set email alerts
|

Antihypertensive agents, serum lipoproteins and glucose metabolism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
24
0

Year Published

1993
1993
2011
2011

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 72 publications
(25 citation statements)
references
References 102 publications
1
24
0
Order By: Relevance
“…The reason for the observed dierences in HDL-C between able-bodied and individuals with SCI are unclear. There are a number of factors that signi®cantly eect HDL-C. For example, cigarette smoking, 36,37 beta blockers or diuretics, 38,39 anti-spastic medication 38 decrease HDL-C, whereas moderate alcohol intake, 40,41 and physical activity 42 increase HDL-C. Diet may also eect HDL-C level although published results are inconsistent.…”
Section: Limitations Of Available Datamentioning
confidence: 99%
“…The reason for the observed dierences in HDL-C between able-bodied and individuals with SCI are unclear. There are a number of factors that signi®cantly eect HDL-C. For example, cigarette smoking, 36,37 beta blockers or diuretics, 38,39 anti-spastic medication 38 decrease HDL-C, whereas moderate alcohol intake, 40,41 and physical activity 42 increase HDL-C. Diet may also eect HDL-C level although published results are inconsistent.…”
Section: Limitations Of Available Datamentioning
confidence: 99%
“…[24][25][26][27] These agents are widely used for the treatment of hypertension and heart disease. Whereas their effects on total cholesterol and triglycerides are known, their effects on cholesterol subfractions is poorly documented.…”
Section: Introductionmentioning
confidence: 99%
“…6,[8][9][10]15 Our results suggest that by using simple anthropomethric and biochemical markers as a test, three-quarters of hypertensive subjects with hyperinsulinaemia у13.0 mU/l and almost all with hyperinsulinaemia у18.0 mU/l become identifiable, and that the test is feasible for both drug-treated and non-treated hypertensives. The weakness in our study is its cross-sectional nature and that the definition of hypertension was based on measurements being made on a single visit.…”
Section: Discussionmentioning
confidence: 99%
“…8,9 To improve the treatment outcome of hypertension at the population level it would be of crucial importance to identify the insulin-resistant hypertensive subjects 10 in clinical practice in order to optimise their pharmacological and non-pharmacological treatment with respect to metabolic abnormalities.…”
Section: Introductionmentioning
confidence: 99%